What if you'd invested in Zoetis (ZTS) ten years ago? It may not have been easy to hold on to ZTS for all that time, but if you did, how much would your investment be worth today? With that in ...

Zoetis raised its annual profit and revenue forecasts on Monday on strong demand for its medicines and vaccines for animals.

Zoetis ZTS has outperformed the market over the past 10 years by 6.56% on an annualized basis producing an average annual return of 18.21%. Currently, Zoetis has a market capitalization of $86.12 ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the fourth quarter of 2024. The dividend will be paid on Tuesday ...

Aristotle Atlantic Core Equity Strategy highlighted stocks like Zoetis Inc. (NYSE:ZTS), in the first quarter 2024 investor letter. Zoetis Inc. (NYSE:ZTS), with a market capitalization of $77.602 ...

Zoetis excels in innovation, creating new categories and consistently raising the standard of care, outperforming competitors with strong execution. Disciplined capital allocation is evident with ...

In the preceding three months, 7 analysts have released ratings for Zoetis ZTS, presenting a wide array of perspectives from bullish to bearish. The following table summarizes their recent ratings ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

Zoetis (NYSE:ZTS – Free Report) had its price objective hoisted by JPMorgan Chase & Co. from $225.00 to $230.00 in a research report released on Friday morning, Benzinga reports. JPMorgan Chase ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In the latest trading session, Zoetis (ZTS) closed at $182.76, marking a +1.53% move from the previous day. This change outpaced the S&P 500's 0.27% gain on the day. Meanwhile, the Dow gained 0.65 ...

Zoetis, Inc. ZTS is expected to beat estimates when it reports its third-quarter 2024 results on Nov. 4, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s ...